Triasima Portfolio Management Inc. Horizon Therapeutics Public LTD CO Transaction History

Triasima Portfolio Management Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$79.4 - $116.36 $345,390 - $506,166	-4,350 Closed	0 $0
Q1 2022 Mar 10, 2023	BUY	$86.42 - $109.81 $375,927 - $477,673	4,350 New	4,350 $458,000
Q1 2022 Jul 20, 2022	SELL	$86.42 - $109.81 $270,926 - $344,254	-3,135 Reduced 41.88%	4,350 $457,000
Q4 2021 Mar 10, 2023	SELL	$98.56 - $119.91 $152,768 - $185,860	-1,550 Reduced 17.16%	7,485 $807,000
Q4 2021 Jul 20, 2022	SELL	$98.56 - $119.91 $152,768 - $185,860	-1,550 Reduced 17.16%	7,485 $809,000
Q3 2021 Mar 10, 2023	SELL	$91.91 - $110.37 $86,854 - $104,299	-945 Reduced 9.47%	9,035 $990,000
Q3 2021 Jul 20, 2022	SELL	$91.91 - $110.37 $86,854 - $104,299	-945 Reduced 9.47%	9,035 $987,000
Q2 2021 Mar 10, 2023	SELL	$86.24 - $95.92 $142,296 - $158,268	-1,650 Reduced 14.19%	9,980 $935,000
Q2 2021 Jul 20, 2022	SELL	$86.24 - $95.92 $142,296 - $158,268	-1,650 Reduced 14.19%	9,980 $934,000
Q4 2020 Mar 10, 2023	BUY	$67.0 - $84.39 $779,210 - $981,455	11,630 New	11,630 $851,000
Q4 2020 Jul 20, 2022	BUY	$67.0 - $84.39 $779,210 - $981,455	11,630 New	11,630 $851,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

Stay updated on Triasima Portfolio Management Inc. with notifications on news.